What are the differential diagnoses for autoimmune hepatitis?

Medical Advisory BoardAll articles are reviewed for accuracy by our Medical Advisory Board
Educational purpose only • Exercise caution as content is pending human review
Article Review Status
Submitted
Under Review
Approved

Last updated: September 30, 2026 • View editorial policy

Have a follow-up question?

Our Medical A.I. is used by practicing medical doctors at top research institutions around the world. Ask any follow up question and get world-class guideline-backed answers instantly.

Ask Question

Differential Diagnosis for Autoimmune Hepatitis

The differential diagnosis of autoimmune hepatitis (AIH) must systematically exclude viral hepatitis, drug-induced liver injury, metabolic dysfunction-associated steatotic liver disease (MASLD), primary biliary cholangitis, primary sclerosing cholangitis, and Wilson's disease, with the specific differential varying based on whether the presentation is acute or chronic. 1

Acute Presentations

For patients presenting acutely with elevated aminotransferases and/or jaundice, prioritize excluding:

  • Viral hepatitis: Test for hepatitis A, B, C, E, CMV, and EBV 1
  • Drug-induced liver injury (DILI): Specifically drug-induced autoimmune-like hepatitis (DIAILH), which can be indistinguishable from AIH with autoantibodies, elevated IgG, and similar histology 2, 1
    • Over 40 substances implicated including minocycline, nitrofurantoin, hydralazine, methyldopa, interferon, imatinib, adalimumab, infliximab, statins, and SARS-CoV-2 vaccines 2
    • Key distinguishing feature: Resolution after drug withdrawal with or without short-course corticosteroids and no relapse suggests DIAILH rather than AIH 2
  • Wilson's disease: Essential to exclude in younger patients 1
  • Vascular causes: Hepatic congestion and ischemic liver injury 1
  • Bile duct stones with acute cholangitis 1

Chronic/Indolent Presentations

For patients with persistently abnormal aminotransferases (>6 months) or cirrhosis at diagnosis:

  • Chronic viral hepatitis: Exclude HBV and HCV first based on serology 2

    • Important caveat: Low-titer autoantibodies appear in ~20% of patients with chronic viral hepatitis, and LKM-positive AIH has been associated with HCV infection 2, 1

  • MASLD/MASH: When steatosis is present on imaging 2, 1

    • Aminotransferases typically lower than AIH (uncommonly >150 U/L) 1
    • Low-titer autoantibodies can appear in ~20% of MASLD patients 2
    • Histologic differentiation: Steatosis, hepatocyte ballooning, Mallory-Denk hyaline, neutrophilic inflammation, and pericentral/perisinusoidal fibrosis suggest MASLD, while plasma cell infiltrates and interface hepatitis suggest AIH 1
    • Critical point: MASLD and AIH can coexist—steatosis is present in 13-35% of AIH patients at diagnosis 1

  • Alcoholic liver disease (ALD): Characteristic AST/ALT ratio patterns help distinguish from AIH 2

  • Primary biliary cholangitis (PBC): Exclude with imaging and specific antimitochondrial antibodies 1

  • Primary sclerosing cholangitis (PSC): Requires cholangiography for diagnosis 1

  • Hepatic congestion: Consider in appropriate clinical context 1

Systemic Autoimmune Diseases

Systemic lupus erythematosus (SLE) presents a particular diagnostic challenge:

  • Most AIH patients have polyarthralgia, and both conditions can show ANA and anti-dsDNA positivity 2
  • Key distinction: Liver involvement is NOT a common manifestation of SLE 2
  • Abnormal liver biochemistry in SLE patients is more commonly due to concurrent MASLD (from corticosteroid use), viral hepatitis, or DILI from SLE therapies 2
  • Anti-dsDNA antibodies do not automatically indicate SLE 2

Coeliac disease should be considered in both acute and chronic hepatitis cases, as it is associated with a 5-fold higher risk of acute hepatitis 2, 1

Diagnostic Challenges and Pitfalls

Autoantibody interpretation requires caution:

  • Autoantibodies and hypergammaglobulinemia may be absent in 15-39% of acute AIH cases 2
  • False-positive autoantibodies can occur with significant liver necrosis 2
  • Cirrhosis causes elevated IgG regardless of etiology 2

Histologic overlap is common:

  • MASLD/MASH can coexist with AIH and share features like lobular inflammation and hepatocyte ballooning, though lobular inflammation is typically less intense in MASLD 2
  • Portal plasma cell-rich inflammation and absence of cholestasis favor AIH over DILI 1
  • Advanced fibrosis may favor AIH over DILI 1
  • Eosinophils are not diagnostically useful for distinguishing DILI from AIH 1

Biliary obstruction must always be excluded with liver imaging (ultrasound ±MRCP) before considering AIH 1

References

Related Questions

In a 49-year-old woman being evaluated for possible autoimmune hepatitis, which laboratory tests and imaging studies are required for diagnosis?
What are the immunologic subtypes of autoimmune hepatitis and how can I determine which type a patient has?
What is the prognosis and recommended treatment for autoimmune hepatitis in a 20-year-old male?
What defines sustained biological remission in autoimmune hepatitis?
What does lymphoplasmacytic infiltration of the liver indicate, and what is its clinical significance in a patient who is 19 weeks pregnant?
Does a patient need to discontinue anticoagulant or antiplatelet therapy before an upper gastrointestinal endoscopy?
In an 80‑year‑old male with a history of atrial fibrillation status post electrical cardioversion, systolic heart failure with improved ejection fraction, previously severe mitral stenosis now resolved, who is currently in sinus rhythm, asymptomatic, and has a resting heart rate of 46 bpm while taking amiodarone 200 mg daily (planned taper to 100 mg) and metoprolol succinate 100 mg daily (reduced to 50 mg), should amiodarone be discontinued?
In a healthy 20‑year‑old male taking sertraline 50 mg daily, can occasional meals cause his blood pressure (BP) to spike?
Is sertraline appropriate for a 20‑year‑old with severe health‑related anxiety, and how many days until improvement in his blood‑pressure checking behavior can be expected?
What is the recommended protocol for switching from fluoxetine 40 mg to duloxetine 30 mg?
What are the possible causes and recommended management for generalized pruritus affecting the arms, legs, toes, and feet?

Professional Medical Disclaimer

This information is intended for healthcare professionals. Any medical decision-making should rely on clinical judgment and independently verified information. The content provided herein does not replace professional discretion and should be considered supplementary to established clinical guidelines. Healthcare providers should verify all information against primary literature and current practice standards before application in patient care. Dr.Oracle assumes no liability for clinical decisions based on this content.